Oncology Central

Landmark study raises the bar for interventional oncology

0

The recent publication of the SIRFLOX trial in the Journal of Clinical Oncology [1] is a landmark for oncologists and radiologists involved in the rapidly advancing field of interventional oncology and liver-directed therapies. The findings are relevant to all oncologists who treat patients with liver metastases.

To view restricted content, please:
Share:

Leave A Comment